The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
CDK7 抑制剂 CT7001 (Samuraciclib) 靶向增殖途径以抑制晚期前列腺癌
期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/s41416-023-02252-8
Theodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, Gilberto Serrano de Almeida, Ellen Olden, Lucy Penfold, Simon Ang, Alice Ormrod, Damien A Leach, Chun-Fui Lai, Edward K Ainscow, Ash K Bahl, David Carling, Matthew J Fuchter, Simak Ali, Charlotte L Bevan
